Influenza vaccination of cancer patients during PD-1 blockade induces serological protection but may raise the risk for immune-related adverse events
Heinz Läubli(University of Basel), Sacha I. Rothschild(University Hospital of Basel)
Cited by 131
Related Papers
Sialic acids in cancer biology and immunity
|Glycobiology|2015|463
Self-associated molecular patterns mediate cancer immune evasion by engaging Siglecs on T cells
|Journal of Clinical Investigation|2018|301
557P Binimetinib, pemetrexed (Pem) and cisplatin (Cis), followed by maintenance of Binimetinib and Pem in patients with advanced non-small cell lung cancer (NSCLC) and KRAS mutations: The phase Ib SAKK 19/16 trial
|Annals of Oncology|2020|1
<i>In vivo</i> screening of TCR-based chimeric antigen receptors for improved anti-tumor functionality
|bioRxiv (Cold Spring Harbor Laboratory)|2025|0